Cipla founding family faces hurdles in stake sale as valuation hits USD 13 billion mark: Bloomberg Farhat Nasim16 Sept 2023 4:42 PM ISTNew Delhi: The sale of a stake in Cipla Ltd. is in jeopardy as potential buyers have balked at the 1.09 trillion rupee ($13.1 billion) valuation...
Cipla Medpro South Africa to acquire Actor Pharma for Rs 403 crore Ruchika Sharma5 Sept 2023 12:42 PM ISTThe transaction is expected to close in the next three to four months.
Nothing to disclose on Cipla stake buy report, says Torrent Pharma Ruchika Sharma2 Sept 2023 1:00 PM ISTBengaluru: India's Torrent Pharmaceuticals on Friday said it has no information requiring disclosure under listing regulations, after the...
USFDA classifies Cipla Pithampur facility as OAI Ruchika Sharma7 Aug 2023 4:30 PM ISTMumbai: Cipla has announced that the Company has received a communication from the United States Food and Drug Administration (USFDA) that the ...
Conduct bioequivalence study: CDSCO Panel Tells Cipla on Arsenic Trioxide Oral Solution Dr. Divya Colin5 Aug 2023 6:00 PM ISTNew Delhi: In response to a proposal presented by drug major Cipla for manufacturing and marketing of the chemotherapeutic agent Arsenic Trioxide Oral...
Cipla US unit recalls 6 batches of Albuterol sulfate inhalation aerosol over container defect Ruchika Sharma7 July 2023 11:26 AM ISTCipla said there were no adverse events reported for the inhaler related to the recall.
Dr Peter Mugyenyi resigns as Independent Director of Cipla Ruchika Sharma15 May 2023 12:27 PM ISTMumbai: Through a recent BSE filing, Cipla has announced that Dr Peter Mugyenyi, Independent Director of the Company has resigned from the position of...
Cipla net profit up 45 percent at Rs 526 crore in Q4 Ruchika Sharma13 May 2023 11:44 AM ISTTotal revenue rose to Rs 22,753 crore last fiscal as against Rs 21,763 crore in 2021-22 fiscal.
Cipla arm gets zero Form 483 observations from USFDA for USA facility Ruchika Sharma3 May 2023 12:30 PM ISTMumbai: Cipla has recently announced that the US Food and Drug Administration has concluded inspection with zero Form 483 observations at the Fall...
Cipla joins hands with Novartis Pharma AG to market diabetes drug Galvus in India Ruchika Sharma10 April 2023 3:10 PM ISTGalvus is one of the leading brands in the Dipeptidyl Peptidase-4 (DPP4) space and amongst the prominent brands in the oral diabetic medication...
Cipla to sell 51 percent stake in Uganda arm for USD 25-30 million Ruchika Sharma15 March 2023 4:00 PM ISTMumbai: Pharma major Cipla Limited and its wholly owned subsidiaries, Cipla (EU) Limited, UK and Meditab Holdings Limited, Mauritius, have entered...
USFDA inspection: Cipla gets 8 observations for Pithampur facility Ruchika Sharma20 Feb 2023 12:15 PM ISTMumbai: Cipla has recently announced that the United States Food and Drug Administration (USFDA) has issued 8 inspectional observations in Form 483...
